Related Experiment Video

Updated: Jul 13, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

[Expression of nuclear transcription factor kappaB in childhood acute lymphoblastic leukemia and its significance]

Tian-Yang Xue1, Wei Xu, Qi An

  • 1Department of Pediatrics, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|August 22, 2007
PubMed

Insights

Nuclear transcription factor kappaB (NF-kappaB) P65 protein is highly expressed in childhood acute lymphoblastic leukemia (ALL) cells. Inhibiting the NF-kappaB pathway may offer a significant therapeutic strategy for childhood ALL.

Area of Science:

  • Molecular Biology
  • Oncology
  • Immunology

Context:

  • Childhood acute lymphoblastic leukemia (ALL) is a significant hematologic malignancy.
  • The role of nuclear transcription factor kappaB (NF-kappaB) in ALL pathogenesis requires further elucidation.
  • Understanding aberrant protein expression is crucial for targeted therapies.

Purpose:

  • To investigate the expression levels of NF-kappaB P65 protein in childhood ALL.
  • To determine the correlation between NF-kappaB P65 expression and clinical characteristics of ALL.
  • To assess the potential of NF-kappaB as a therapeutic target in childhood ALL.

Summary:

  • NF-kappaB P65 protein expression was significantly higher in childhood ALL patients (87.50%) compared to controls (12.50%).
  • Strong positive expression of NF-kappaB P65 was observed in a substantial proportion of ALL cases.
  • No significant differences in NF-kappaB P65 levels were found concerning morphology, immunophenotype, or disease course (de novo vs. relapsed).

Impact:

  • This study highlights the aberrant expression of NF-kappaB P65 in childhood ALL.
  • Findings suggest that targeting the NF-kappaB transduction pathway could be a promising therapeutic approach.
  • Provides an experimental basis for considering NF-kappaB as a clinical treatment target for ALL.

More Related Videos

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...